Halle C. F. Moore, MD | Authors

Meta-Analysis: GnRH Analog Preserves Ovarian Function in Early Breast Cancer

December 14, 2017

This video reviews a meta-analysis that looked at five studies testing the use of a gonadotropin-releasing hormone (GnRH) analog to protect ovarian function and preserve fertility in premenopausal women undergoing chemotherapy for early-stage breast cancer.

An Overview of Chemotherapy-Related Cognitive Dysfunction, or ‘Chemobrain’

September 15, 2014

This review will focus largely on the effects of systemic cytotoxic treatment on cognitive function, reflecting what has been most extensively studied in the literature.